Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DECIDE- Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression -Study

NCT06396312 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.

NCT NCT06396312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06396312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DECIDE- Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression -Study
Lead sponsor
Max-Planck-Institute of Psychiatry
Phase
Observational
Overall status
Recruiting
Start date
April 2, 2024
Completion date
April 1, 2029
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, moderate, depressive disorder, major, recurrent, with psychotic symptoms, depressive disorder, major, recurrent, without psychotic symptoms, depressive disorder, major, severe, depressive disorder, treatment-resistant, class i or ii, depressive; disorder, major, single episode, major (without psychotic symptoms), depressive; disorder, major, single episode, major, with psychotic symptoms